Pulmonary arterial hypertension in systemic sclerosis: a distinctive endotheliopathy?

Orfanos S. E., Langleben D.

Source: Eur Respir J 2010; 35: 223-224
Journal Issue: January
Disease area: Pulmonary vascular diseases

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Orfanos S. E., Langleben D.. Pulmonary arterial hypertension in systemic sclerosis: a distinctive endotheliopathy?. Eur Respir J 2010; 35: 223-224

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Screening for pulmonary arterial hypertension in systemic sclerosis
Source: Eur Respir Rev 2009; 18: 162-169
Year: 2009



Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy
Source: Eur Respir J 2009; 33: 371-379
Year: 2009



Pulmonary hypertension in systemic sclerosis: different phenotypes
Source: Eur Respir Rev, 26 (145) 170056; 10.1183/16000617.0056-2017
Year: 2017



Pulmonary arterial hypertension: an autoimmune disease?
Source: Eur Respir J 2005; 26: 986-988
Year: 2005


Pulmonary arterial hypertension in scleroderma – manifestation of systemic endothelial dysfunction
Source: Eur Respir J 2006; 28: Suppl. 50, 548s
Year: 2006

Risk factors associated with pulmonary arterial hypertension in patients with systemic sclerosis and implications for screening
Source: Eur Respir Rev 2011; 20: 270-276
Year: 2011



Pulmonary hypertension in systemic scleroderma
Source: Eur Respir J 2003; 22: Suppl. 45, 269s
Year: 2003

Stress-Doppler-Echocardiography for early detection of systemic sclerosis associated pulmonary arterial hypertension
Source: International Congress 2014 – Modern approach and old dilemmas in lung diseases
Year: 2014


Identifying early pulmonary arterial hypertension in patients with systemic sclerosis
Source: Eur Respir J, 51 (4) 1800495; 10.1183/13993003.00495-2018
Year: 2018



Vasodilator testing in pulmonary arterial hypertension associated with systemic sclerosis
Source: Eur Respir J 2006; 28: Suppl. 50, 548s
Year: 2006

Pulmonary hypertension and arterial stiffness in patients with systemic scleroderma
Source: Annual Congress 2010 - Pulmonary circulation I
Year: 2010

Risk assessment in patients with systemic sclerosis and pulmonary arterial hypertension
Source: Eur Respir J, 52 (4) 1801745; 10.1183/13993003.01745-2018
Year: 2018



Lung function and pulmonary hypertension in systemic sclerosis
Source: Eur Respir J 2006; 28: Suppl. 50, 548s
Year: 2006

Differences between limited and diffuse systemic sclerosis-related pulmonary arterial hypertension
Source: Annual Congress 2011 - Clinical features of pulmonary hypertension
Year: 2011

Idiopathic and systemic sclerosis-associated PAH: A comprehensive haemodynamic and radiological comparison
Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology
Year: 2016

Trends in systemic sclerosis and systemic sclerosis-related pulmonary arterial hypertension mortality in the USA
Source: ERJ Open Res, 6 (2) 00309-2019; 10.1183/23120541.00309-2019
Year: 2020



Pulmonary involvement in systemic sclerosis
Source: Eur Respir Monogr 2019; 86: 90-105
Year: 2019


Pulmonary function in progressive systemic sclerosis
Source: Eur Respir J 2002; 20: Suppl. 38, 62s
Year: 2002

Pulmonary arterial hypertension in connective tissue diseases
Source: Eur Respir Mon 2012; 57: 42-57
Year: 2012


Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertension
Source: Eur Respir J, 52 (4) 1800678; 10.1183/13993003.00678-2018
Year: 2018